Academic Journal
View in EDS

A dose finding, safety and pharmacokinetic study of AVE1642, an anti-insulin-like growth factor-1 receptor (IGF-1R/CD221) monoclonal antibody, administered as a single agent and in combination with docetaxel in patients with advanced solid tumours

Bibliographic Details
Title: A dose finding, safety and pharmacokinetic study of AVE1642, an anti-insulin-like growth factor-1 receptor (IGF-1R/CD221) monoclonal antibody, administered as a single agent and in combination with docetaxel in patients with advanced solid tumours
Authors: Soria, Jean Charles, Massard, Christophe, Lazar, Vladimir, Ozoux, Marie-Laure, Mery-Mignard, Dominique, Deslandes, Antoine, Tolcher, Anthony W.
Source: In European Journal of Cancer May 2013 49(8):1799-1807
Database: ScienceDirect
More Details
ISSN:09598049
DOI:10.1016/j.ejca.2013.01.003
Published in:European Journal of Cancer
Language:English